Deniz Gayrimenkul Yatirim Ortakligi A.S. (IST:DZGYO)

G1 Therapeutics Balance Sheet

Financials in millions TRY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	55.59	0.04	36.23	675.12	5.83	3
Short-Term Investments	1,373	-	-	32.62	-	-
Trading Asset Securities	-	1,178	314.69	-	-	-
Cash & Short-Term Investments	1,429	1,178	350.92	707.74	5.83	3
Cash Growth	300.94%	235.67%	-50.42%	12033.19%	94.32%	-88.00%
Accounts Receivable	1.47	1.45	1.84	49.65	10.3	2.61
Other Receivables	0.28	2.43	-	2.15	22.06	0
Receivables	1.75	3.88	1.84	51.8	32.36	2.61
Inventory	622.9	533.89	618.9	898.64	579.95	620.39
Prepaid Expenses	2.48	0.81	3.48	3.02	0.29	0.39
Other Current Assets	1.73	1.39	422.65	2.37	1.77	1.92
Total Current Assets	2,058	1,718	1,398	1,664	620.2	628.31
Property, Plant & Equipment	1,528	19.07	26.04	22.32	6.99	6.55
Other Long-Term Assets	2,065	3,048	2,298	1,169	379.32	418.65
Total Assets	5,651	4,785	3,722	2,855	1,007	1,054
Accounts Payable	13.32	2.79	3.4	0.33	0.01	119.63
Accrued Expenses	6.23	14.32	43.67	7.26	2.12	1.55
Short-Term Debt	-	-	-	-	19.47	289.25
Current Portion of Leases	13.13	7.04	3.06	1.78	0.82	1.19
Current Unearned Revenue	2.3	606.49	2.18	68.35	36.49	24.12
Other Current Liabilities	20.68	21.08	31.03	323.81	225.45	148.43
Total Current Liabilities	66.57	651.72	83.33	401.53	284.36	584.17
Long-Term Leases	3.13	2.06	-	1.86	2.03	2.09
Long-Term Unearned Revenue	770.41	-	-	-	-	1.53
Other Long-Term Liabilities	8.43	14.63	-	-	-	94
Total Liabilities	848.63	668.7	84.24	404.38	286.57	682.06
Common Stock	400	400	400	400	400	150
Additional Paid-In Capital	675.23	578.73	578.73	400.84	54.94	54.69
Retained Earnings	1,368	1,173	694.2	411.94	264.95	166.82
Comprehensive Income & Other	2,360	1,965	1,964	1,237	0.05	-0.05
Shareholders' Equity	4,803	4,117	3,637	2,450	719.94	371.46
Total Liabilities & Equity	5,651	4,785	3,722	2,855	1,007	1,054
Total Debt	16.26	9.1	3.06	3.64	22.32	292.53
Net Cash (Debt)	1,413	1,169	347.86	704.09	-16.49	-289.53
Net Cash Growth	306.84%	236.01%	-50.59%	-	-	-
Net Cash Per Share	3.53	2.92	0.87	1.76	-0.05	-3.35
Filing Date Shares Outstanding	400	400	400	400	400	150
Total Common Shares Outstanding	400	400	400	400	400	150
Working Capital	1,991	1,066	1,314	1,262	335.84	44.14
Book Value Per Share	12.01	10.29	9.09	6.13	1.80	2.48
Tangible Book Value	4,803	4,117	3,637	2,450	719.94	371.46
Tangible Book Value Per Share	12.01	10.29	9.09	6.13	1.80	2.48
Machinery	41.27	36.65	36.03	24.13	6.89	4.91

Source: S&P Global Market Intelligence. Standard template. Financial Sources.